Liquidia Corp (LQDA) - Gross Margin

Official company branding of Liquidia Corp (LQDA)

Analyzing the gross margin level on GURU.Markets, it is evident how the 92.60 metric determines the status of the efficiency parameter. Liquidia Corporation (LQDA) optimizes the development of drug delivery methods by outsourcing production and testing to third-party contractors. Expected triggers for a full-scale market launch are forming, and legal costs are already priced in. The biotech's ultimate success relies on the commercialization of inhaled treprostinil and the expansion of insurance coverage.

LQDA Liquidia Corp Gross Margin (07/04/2022 - 11/20/2026)

Financial and market metric breakdowns for Liquidia Inc. (LQDA)

- market price and analyst price targets:
- market capitalization indicators:
Summary company analysis:Liquidia (LQDA)
Mass-produced product of Liquidia Technologies

For the investor, the stability of the Liquidia Corporation (LQDA) business model depends on the ability to minimize costs given a high reliance on a single therapeutic area for the treatment of pulmonary hypertension. Analyzing the gross margin allows for an assessment of production and pricing efficiency, as this metric measures the portion of revenue remaining after deducting direct costs, serving as an indicator of profit growth potential or asset overheating.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Gross Sales Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin